BRK-B vs GEMI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GEMI exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic ROE of -416.47%. While the company shows strong top-line revenue growth of 39.40%, this is completely offset by a negative gross margin (-25.78%) and an operating margin of -183.54%, indicating that the company loses money on every unit of service provided. The stock is in a technical freefall, down over 84% in the last year, and is consistently missing earnings estimates by wide margins.
Compare Another Pair
Related Comparisons
BRK-B vs GEMI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Gemini Space Station, Inc. (GEMI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.